Literature DB >> 27128596

Endovascular therapy of low- and intermediate-grade intracranial lateral dural arteriovenous fistulas: a detailed analysis of primary success rates, complication rates, and long-term follow-up of different technical approaches.

Lorenz Ertl1, Hartmut Brückmann1, Mathias Kunz2, Alexander Crispin3, Gunther Fesl1.   

Abstract

OBJECTIVE Sinus-preserving (SP) embolization techniques augment endovascular treatment options for intracranial lateral dural arteriovenous fistulas (DAVFs). The authors aimed to perform a retrospective comparison of their primary success rates, complication rates, and long-term follow-up with those of sinus-occluding (SO) treatment variants in the collective of low- and intermediate-grade lateral DAVFs (Cognard Types I-IIb). METHODS Clinical symptoms, complication rates, and Cognard grading prior to and after endovascular DAVF treatment using different technical approaches was retrospectively analyzed in 36 patients with lateral DAVF Cognard Types I-IIb. The long-term success rate was determined by a standardized questionnaire. RESULTS The SO approaches offered a higher rate of definitive fistula occlusion (93% SO vs 71% SP) but were accompanied by a significantly higher complication rate (33% or 20% SO vs 0% SP). The patients interviewed reported very high satisfaction with their health in long-term follow-up in both groups. CONCLUSIONS A higher rate of definitive fistula occlusion in the SO group was attained at the price of a significantly higher complication rate. The SP approaches offered a good primary success rate in combination with a very low complication rate. Despite some limitations of the data (e.g., a small sample size) the authors thus recommend an SP variant as the primary therapeutic option for the endovascular treatment of low- and intermediate-grade DAVFs. The SO approaches should be restricted to cases in which SP treatment does not achieve a downgrading to no worse than Cognard Type IIa.

Entities:  

Keywords:  CCA = common carotid artery; CCF = carotid cavernous fistula; CSOE = combined sinus-occluding embolization; CSPE = combined sinus-preserving embolization; DAVF = dural arteriovenous fistula; DSA = digital subtraction angiography; ECA = external carotid artery; SO = sinus-occluding; SP = sinus-preserving; TAE = transarterial embolization; TVE = transvenous embolization; endovascular treatment; interventional neurosurgery; intracranial fistula; therapy assessment

Mesh:

Year:  2016        PMID: 27128596     DOI: 10.3171/2016.2.JNS152081

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Outcome Following Hemorrhage From Cranial Dural Arteriovenous Fistulae: Analysis of the Multicenter International CONDOR Registry.

Authors:  Matthew J Koch; Christopher J Stapleton; Ridhima Guniganti; Giuseppe Lanzino; Jason Sheehan; Ali Alaraj; Diederik Bulters; Louis Kim; W Christopher Fox; Bradley A Gross; Minako Hayakawa; J Marc C van DijK; Robert M Starke; Junichiro Satomi; Adam J Polifka; Gregory J Zipfel; Sepideh Amin-Hanjani
Journal:  Stroke       Date:  2021-08-26       Impact factor: 10.170

2.  Transarterial Treatment of Cranial Dural Arteriovenous Fistulas: The Role of Transarterial and Transvenous Balloon-Assisted Embolization.

Authors:  J O Zamponi; F P Trivelato; M T S Rezende; R K Freitas; L H de Castro-Afonso; G S Nakiri; T G Abud; A C Ulhôa; D G Abud
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-01       Impact factor: 3.825

3.  The Influence of Angioarchitectural Features on the Success of Endovascular Embolization of Cranial Dural Arteriovenous Fistulas with Onyx.

Authors:  D F Vollherbst; C Herweh; S Schönenberger; F Seker; S Nagel; P A Ringleb; M Bendszus; M A Möhlenbruch
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-21       Impact factor: 3.825

4.  Target Coil Embolization Using the Combined Transarterial and Transvenous Balloon-assisted Technique for Traumatic Direct Carotid Cavernous Fistula.

Authors:  Ryotaro Suzuki; Tomoji Takigawa; Yoshiyuki Matsumoto; Yoshiko Fujii; Yasuhiko Nariai; Yoshiki Sugiura; Yosuke Kawamura; Issei Takano; Yoshihiro Tanaka; Masaya Nagaishi; Akio Hyodo; Kensuke Suzuki
Journal:  NMC Case Rep J       Date:  2021-04-02

5.  Scepter dual-lumen balloon catheter for Onyx embolization for dural arteriovenous fistula.

Authors:  Chang Ki Jang; Byung Moon Kim; Keun Young Park; Jae Whan Lee; Dong Joon Kim; Joonho Chung; Jun-Hwee Kim
Journal:  BMC Neurol       Date:  2021-01-20       Impact factor: 2.474

6.  Ear ischemia induced by endovascular therapy for arteriovenous fistula of the sigmoid sinus: A case report.

Authors:  Wei Li; Sui-Sui Zhang; Xiao-Ran Gao; You-Xiang Li; Hui-Jian Ge
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

7.  Intra-operative emergence of occult dural arteriovenous fistula after middle meningeal artery embolization for chronic subdural hematoma: Case report and literature review.

Authors:  Armin Tavakkoli; Julio D Montejo; Daniel R Calnan; Timothy C Ryken; Clifford J Eskey
Journal:  Radiol Case Rep       Date:  2022-03-03

8.  Contralateral Transverse Sinus Occlusion After Treatment of Transverse-Sigmoid Sinus Dural Arteriovenous Fistula: A Case Report.

Authors:  Jung Hwan Lee; Jae Il Lee; Jun Kyeung Ko; Tae Hong Lee; Chang Hwa Choi
Journal:  Korean J Neurotrauma       Date:  2022-02-14

Review 9.  Updates in the management of cranial dural arteriovenous fistula.

Authors:  Humain Baharvahdat; Yinn Cher Ooi; Wi Jin Kim; Ashkan Mowla; Alexander L Coon; Geoffrey P Colby
Journal:  Stroke Vasc Neurol       Date:  2019-11-21

10.  Radiation Dose and Fluoroscopy Time of Endovascular Treatment in Patients with Intracranial Lateral Dural Arteriovenous Fistulae.

Authors:  Robert Forbrig; Robert Stahl; Lucas L Geyer; Yigit Ozpeynirci; Thomas Liebig; Christoph G Trumm
Journal:  Clin Neuroradiol       Date:  2020-12-11       Impact factor: 3.649

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.